Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers.

Novel tools are necessary to understand mechanisms of altered susceptibility to HIV-1 infection in women of the Pumwani Sex Worker cohort, Kenya. In this cohort, more than 140 of the 2000 participants have been characterized to be relatively resistant to HIV-1 infection. Given that sexual transmission of HIV-1 occurs through mucosal surfaces such as that in the cervicovaginal environment, our hypothesis is that innate immune factors in the genital tract may play a role in HIV-1 infection resistance. Understanding this mechanism may help develop microbicides and/or vaccines against HIV-1. A quantitative proteomics technique (2D-DIGE: two-dimensional difference in-gel electrophoresis) was used to examine cervical mucosa of HIV-1 resistant women ( n = 10) for biomarkers of HIV-1 resistance. Over 15 proteins were found to be differentially expressed between HIV-1-resistant women and control groups ( n = 29), some which show a greater than 8-fold change. HIV-1-resistant women overexpressed several antiproteases, including those from the serpin B family, and also cystatin A, a known anti-HIV-1 factor. Immunoblotting for a selection of the identified proteins confirmed the DIGE volume differences. Validation of these results on a larger sample of individuals will provide further evidence these biomarkers are associated with HIV-1 resistance and could help aid in the development of effective microbicides against HIV-1.

[1]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[2]  P Piot,et al.  HIV infection among lower socioeconomic strata prostitutes in Nairobi. , 1990, AIDS.

[3]  N. Nagelkerke,et al.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya , 1996, The Lancet.

[4]  G. Silverman,et al.  Squamous Cell Carcinoma Antigen 2 Is a Novel Serpin That Inhibits the Chymotrypsin-like Proteinases Cathepsin G and Mast Cell Chymase* , 1997, The Journal of Biological Chemistry.

[5]  J. Orenstein,et al.  Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1 , 1997 .

[6]  S. Dasari,et al.  Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. , 2007, Journal of proteome research.

[7]  N. Kanayama,et al.  Increased Risk of Intrauterine Transmission of HIV-1 Associated With Granulocyte Elastase in Endocervical Mucus , 2006, Journal of acquired immune deficiency syndromes.

[8]  G. Priebe,et al.  The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection , 2007, The Journal of experimental medicine.

[9]  E. Dalmasso,et al.  Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. , 2002, Science.

[10]  T. Quinn,et al.  HIV/AIDS in Women: An Expanding Epidemic , 2005, Science.

[11]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[12]  C. de Beer,et al.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay , 2006, Virology Journal.

[13]  S. Challacombe,et al.  Oral mucosal immunity and HIV infection: current status. , 2002, Oral diseases.

[14]  S. Rowland-Jones,et al.  HIV Type 1 Resistance in Kenyan Sex Workers Is Not Associated with Altered Cellular Susceptibility to HIV Type 1 Infection or Enhanced β-Chemokine Production , 1998 .

[15]  E. Diamandis,et al.  Proteomic analysis of human cervico-vaginal fluid. , 2007, Journal of proteome research.

[16]  L. Congote.  The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1. , 2006, Biochemical and biophysical research communications.

[17]  M. Robb,et al.  Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. , 1999, The Journal of infectious diseases.

[18]  S. Lee-Huang,et al.  Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Kaul,et al.  HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. , 1999, AIDS.

[20]  B. Guy,et al.  A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein , 1991, Journal of virology.

[21]  A. Fauci,et al.  Cathepsin G, a Neutrophil-Derived Serine Protease, Increases Susceptibility of Macrophages to Acute Human Immunodeficiency Virus Type 1 Infection , 2000, Journal of Virology.

[22]  Ji Ming Wang,et al.  Identification of Human Neutrophil-derived Cathepsin G and Azurocidin/CAP37 as Chemoattractants for Mononuclear Cells and Neutrophils , 1997, The Journal of experimental medicine.

[23]  E. Remold-O’Donnell,et al.  Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F Gharahdaghi,et al.  Mass spectrometric identification of proteins from silver‐stained polyacrylamide gel: A method for the removal of silver ions to enhance sensitivity , 1999, Electrophoresis.

[25]  L. Lopalco,et al.  Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. , 1999, The Journal of infectious diseases.

[26]  M. Dierich,et al.  Complement-opsonized HIV: the free rider on its way to infection. , 2005, Molecular immunology.

[27]  S. Arya,et al.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.

[28]  David P. Kreil,et al.  Determining a significant change in protein expression with DeCyder™ during a pair‐wise comparison using two‐dimensional difference gel electrophoresis , 2004, Proteomics.

[29]  A. Kulkarni,et al.  Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing , 2000, Nature Medicine.

[30]  C. McCollum,et al.  Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[31]  S. Rowland-Jones,et al.  HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. , 1998, AIDS research and human retroviruses.

[32]  K. Kaibuchi,et al.  Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). , 2006, Blood.

[33]  Y. Kooyk,et al.  DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission. , 2003, Current topics in microbiology and immunology.

[34]  C. Hsieh,et al.  Protection from HIV-1 infection by HIV-2. , 1998, AIDS.

[35]  K. Mitsudo,et al.  Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. , 2003, Archives of biochemistry and biophysics.

[36]  L. Congote,et al.  The C‐terminal 26‐residue peptide of serpin A1 stimulates proliferation of breast and liver cancer cells: role of protein kinase C and CD47 , 2004, FEBS letters.

[37]  T. Ball,et al.  Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. , 2005, The Journal of infectious diseases.

[38]  L. Panin,et al.  Interaction of Human Apolipoprotein A-I with rsCD4 Receptor , 2002, Bulletin of Experimental Biology and Medicine.

[39]  Wuyuan Lu,et al.  N‐terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4‐68 variant , 2006, Journal of leukocyte biology.

[40]  P. Kaleebu,et al.  Expression of the common heat‐shock protein receptor CD91 is increased on monocytes of exposed yet HIV‐1‐seronegative subjects , 2005, Journal of leukocyte biology.

[41]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[42]  R. Kaul,et al.  Prostitutes in Nairobi Responses in the Cervix of HIV-1-Resistant Lymphocyte + HIV-1-Specific Mucosal CD 8 , 2000 .

[43]  W. Schaffner,et al.  The large subunit of HIV-1 reverse transcriptase interacts with beta-actin. , 1995, Nucleic acids research.

[44]  L. Lopalco,et al.  Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. , 2002, Journal of acquired immune deficiency syndromes.

[45]  Christina H. Park,et al.  Antimicrobial components of vaginal fluid. , 2002, American journal of obstetrics and gynecology.

[46]  E. Toulza,et al.  A Novel Protease Inhibitor of the α2-Macroglobulin Family Expressed in the Human Epidermis* , 2006, Journal of Biological Chemistry.

[47]  A. Cole,et al.  Cationic Polypeptides Are Required for Anti-HIV-1 Activity of Human Vaginal Fluid1 , 2005, The Journal of Immunology.

[48]  T. Geijtenbeek,et al.  Viral piracy: HIV-1 targets dendritic cells for transmission. , 2006, Current HIV research.

[49]  S. Westmoreland,et al.  Rapid dissemination of SIV following oral inoculation , 2004, AIDS.

[50]  E. Dalmasso,et al.  Contribution of Human α-Defensin 1, 2, and 3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor , 2002, Science.

[51]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[52]  M A Horan,et al.  Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. , 1999, The American journal of pathology.

[53]  R. Silverstein,et al.  Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva , 1998, The Journal of experimental medicine.

[54]  R. Compans,et al.  Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. , 1990, The Journal of clinical investigation.

[55]  R. Wait,et al.  A modified silver staining protocol for visualization of proteins compatible with matrix‐assisted laser desorption/ionization and electrospray ionization‐ mass spectrometry , 2000, Electrophoresis.

[56]  D. Dripps,et al.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. , 1995, The Journal of clinical investigation.

[57]  T. Hodge,et al.  Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1. , 2001, AIDS research and human retroviruses.

[58]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[59]  W. Nacken,et al.  Myeloid-related protein (MRP)-8 from cervico-vaginal secretions activates HIV replication , 2001, AIDS.

[60]  J. Ruysschaert,et al.  Apolipoprotein A-1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41: implications in viral entry. , 1992, Biochemical and Biophysical Research Communications - BBRC.